Ligand Pharmaceuticals, Inc. (LGND)
280.18
-6.11
(-2.13%)
USD |
NASDAQ |
Aug 24, 16:00
280.04
-0.14
(-0.05%)
After-Hours: 20:00
Ligand Pharmaceuticals Total Liabilities (Quarterly) : 1.218B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.218B |
| March 31, 2026 | 534.78M |
| December 31, 2025 | 543.42M |
| September 30, 2025 | 526.60M |
| June 30, 2025 | 120.08M |
| March 31, 2025 | 109.90M |
| December 31, 2024 | 111.34M |
| September 30, 2024 | 113.69M |
| June 30, 2024 | 91.21M |
| March 31, 2024 | 107.35M |
| December 31, 2023 | 86.30M |
| September 30, 2023 | 101.33M |
| June 30, 2023 | 93.21M |
| March 31, 2023 | 164.76M |
| December 31, 2022 | 165.18M |
| September 30, 2022 | 234.31M |
| June 30, 2022 | 273.92M |
| March 31, 2022 | 311.99M |
| December 31, 2021 | 476.43M |
| September 30, 2021 | 461.59M |
| June 30, 2021 | 469.77M |
| March 31, 2021 | 549.28M |
| December 31, 2020 | 652.76M |
| September 30, 2020 | 549.62M |
| June 30, 2020 | 547.93M |
| Date | Value |
|---|---|
| March 31, 2020 | 524.02M |
| December 31, 2019 | 727.68M |
| September 30, 2019 | 696.90M |
| June 30, 2019 | 760.38M |
| March 31, 2019 | 834.01M |
| December 31, 2018 | 751.86M |
| September 30, 2018 | 1.406B |
| June 30, 2018 | 1.238B |
| March 31, 2018 | 273.57M |
| December 31, 2017 | 341.72M |
| September 30, 2017 | 259.17M |
| June 30, 2017 | 254.91M |
| March 31, 2017 | 257.89M |
| December 31, 2016 | 260.30M |
| September 30, 2016 | 262.61M |
| June 30, 2016 | 259.56M |
| March 31, 2016 | 221.36M |
| December 31, 2015 | 265.78M |
| September 30, 2015 | 229.52M |
| June 30, 2015 | 235.71M |
| March 31, 2015 | 230.83M |
| December 31, 2014 | 233.62M |
| September 30, 2014 | 229.50M |
| June 30, 2014 | 36.76M |
| March 31, 2014 | 40.47M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
| Merck & Co., Inc. | 87.82B |
| Zevra Therapeutics, Inc. | 85.06M |
| Liquidia Corp. | 326.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.186B |
| Shareholders Equity (Quarterly) | 967.52M |
| Debt to Equity Ratio | 1.169 |
| Current Ratio | 31.18 |
| Net Debt Paydown Yield | -3.58% |